Naproxen oral absorption characteristics.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism*; D002214:Capsules; D004285:Dogs; D006801:Humans; D007275:Injections, Intravenous; D008738:Methyl Ethers / Q000378:metabolism; D009281:Naphthalenes / Q000008:administration & dosage / Q000378:metabolism; D011422:Propionates / Q000008:administration & dosage / Q000378:metabolism*; D013535:Suspensions; D013607:Tablets
D000893:Anti-Inflammatory Agents; D002214:Capsules; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D013535:Suspensions; D013607:Tablets